Lincoln Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication with respect to Unaudited (Standalone & Consolidated) Financial Results for the Quarter ended 30.06.2025.
LINCOLN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Lincoln Pharmaceuticals has submitted copies of the newspaper advertisement publishing its unaudited standalone and consolidated financial results for the quarter ended June 30, 2025, as required under SEBI Listing Regulations. The results were approved by the Board of Directors at a meeting held on August 7, 2025, and the advertisement appeared in Financial Express in both English and Gujarati editions on August 8, 2025. The full financial results and the auditor's limited review report are available on the company's website and on the BSE and NSE websites. No specific financial figures are included in this filing, as it serves only as the public notice of the results that were already filed separately.
This is a routine regulatory compliance filing with no new financial details, so it is unlikely to cause any share price movement on its own. Investors should refer to the separately filed detailed Q1 results for actual performance numbers and outlook.